How Do You Prove a Scope Caused Your Infection?

Timing alone is not proof. Plenty of people who feel sick after a procedure were not made sick by the device, and a defense lawyer will say so on day one. What separates a strong scope-infection claim from a hunch is the same thing that separates a solved outbreak from an open one: hard laboratory evidence that ties the exact organism growing in the patient to the exact scope that was used. That evidence exists, it is generated by neutral third parties — hospital microbiology labs, state public health departments, and the CDC — and it follows a recognized method. This article walks through the three layers of that method and explains why they matter when a case is built.

The Three Layers of Proof

Proving a device caused an infection is not one test; it is a chain of evidence, and each link makes the next one stronger. The first layer is epidemiology — the pattern. Investigators look for a cluster: several patients who all had a procedure with the same instrument and then grew the same unusual organism within a similar window of time. The second layer is device sampling — culturing the scope itself to see whether the same bug is actually living on it. The third layer is DNA fingerprinting — comparing the genetic code of the patient’s organism with the one recovered from the scope, and with organisms from other affected patients, to see whether they are truly the same strain. Any one layer, standing alone, can be argued away. Together, they build a picture that is hard to dismiss as coincidence.

Layer One: The Cluster That Started It

Almost every documented scope outbreak began with an infection-control nurse or microbiologist noticing something that did not fit — a rare, drug-resistant organism showing up in more patients than chance would explain, and those patients sharing one thing in common: a recent endoscopy. That is classic outbreak epidemiology. When a bug as unusual as carbapenem-resistant Enterobacterales (CRE) appears in a cluster, it demands an explanation, because CRE is exactly the kind of organism the reusable-scope design is prone to trapping. We explain that organism in detail in our piece on what CRE is and why it sits at the center of the scope infections. The cluster is the alarm bell; it tells investigators where to look. But a shared procedure is only a correlation. To move from “these patients all had endoscopies” to “this device infected them,” the investigation has to reach the machine itself.

Layer Two: Culturing the Scope

After the FDA and CDC recognized that reusable duodenoscopes could stay contaminated even after correct cleaning, the CDC issued an Interim Duodenoscope Surveillance Protocol in 2015 so facilities could actually test their scopes. The method is straightforward: staff brush the scope’s distal tip and flush its internal channel with a sterile solution, then send that sample to a laboratory to be cultured. If the same organism that is sickening patients grows out of the scope, the device is no longer a suspect in theory — it is a suspect with the fingerprints still on it.

Two things make this layer powerful in hindsight. First, some facilities run ongoing surveillance cultures and keep the results. The CDC has noted that a duodenoscope culture database can be used to trace an infection back to a specific device — meaning a facility may already hold a dated record of what was growing on that exact scope, by serial number, around the time of a patient’s procedure. Second, this is the reprocessing-side companion to the physical evidence we describe in our article on what borescope inspections reveal inside “clean” scopes: a culture says a bug is present, and a borescope can show the scratches and channel damage that let it hide there. One explains the other.

Layer Three: DNA Fingerprinting the Superbug

The most decisive layer is genetic. Two patients can grow “the same” species — say, Klebsiella pneumoniae — and still have been infected from completely different sources, because that species is common. What tells investigators whether it is truly one strain traveling from a single source is a comparison of the bacteria’s DNA. For decades the workhorse method was pulsed-field gel electrophoresis (PFGE), a technique that cuts each organism’s DNA into fragments and produces a banding pattern — a kind of barcode — that can be lined up side by side. The CDC’s national PulseNet system used PFGE for years to connect cases across the country.

The newer and sharper tool is whole-genome sequencing (WGS), which reads the organism’s entire genetic code and lets scientists compare two samples down to individual DNA letters. Its higher resolution can distinguish strains that older methods would have called identical, and it can confirm a match with far greater confidence. When the organism from a patient, the organism cultured from the scope, and the organisms from other affected patients all share the same genetic fingerprint, the argument that the scope was “probably not” the source becomes very difficult to sustain. This is not hypothetical: in a well-documented 2013 outbreak at an Illinois hospital, investigators used molecular characterization to tie NDM-producing, carbapenem-resistant E. coli infections to exposure to ERCP duodenoscopes — findings later published in JAMA. Researchers have since used WGS to detect and confirm additional endoscopy-associated outbreaks the same way.

Why This Matters for a Legal Case

Causation is the hinge of a scope-infection claim. It is not enough to show a patient got sick and a device was involved; the law asks whether that device, more likely than not, caused this injury. The three-layer method is how that question gets answered with evidence instead of argument. A matched genetic fingerprint between a patient’s isolate and a scope’s isolate does for a scope case what it does for a foodborne-illness case: it converts “it could have been anything” into “it was this.”

That evidence also has to be found and protected before it disappears, which is why early action matters. Bacterial isolates from patients are sometimes retained by hospital or public health laboratories, but not forever. Device-tracking logs, reprocessing records, and any surveillance-culture history are kept on routine retention schedules and can be purged. We lay out exactly what to ask for, and how quickly, in our guide to requesting and preserving hospital records after a scope infection. And the causation science does not decide fault by itself — it fits into the two-track framework behind every scope claim: hospital reprocessing negligence on one side and product liability against the manufacturer on the other.

What About an Isolated Case?

Most people who are hurt by a contaminated scope were never part of a headline outbreak. Their infection was a single event, quietly logged in a chart. That does not put the evidence out of reach. The same tools work on a smaller scale: the organism cultured from the patient, the device-tracking record naming the exact scope used, any culture history for that scope, and — where the isolate was saved — a DNA comparison. Contaminated Olympus duodenoscopes have been linked to documented outbreaks at hospitals across the United States, and each of those investigations was built the same way, one record and one isolate at a time. Whether an individual has a claim always depends on the specific facts and the strength of the causation evidence.

A Trial Lawyer’s Read

“Defense lawyers in these cases love ambiguity — ‘he was already sick, hospitals are full of germs, you can’t prove where it came from,’” says Alex Alvarez, Managing Partner of The Alvarez Law Firm and a Board Certified Civil Trial Lawyer. “The genetic evidence takes that ambiguity away. When the strain in my client’s bloodstream is a DNA match to the strain on the scope and to the other patients in that unit, that is not a coincidence anymore — that is a chain of custody for a superbug. So I want the device-tracking log by serial number, the surveillance cultures for that scope, and whether the patient isolates were preserved. Those three things tell me how strong the causation case really is.”

The medical records have to line up with the lab work. “My job is to read whether the documents actually support the connection or rule it out,” notes Herb Borroto, M.D., J.D., the firm’s Medical-Legal Expert, who holds both a medical degree and a law degree. “I’m matching the organism and its resistance pattern, the date the culture was drawn, and the procedure date against the device records — and, when it exists, the genetic typing. If a patient grew a resistant organism, that same organism was cultured off the scope, and the sequencing calls them the same strain, the pieces fit. If they don’t fit, I say so. The science is only useful if you read it honestly.”

What to Do Now

If you or a loved one developed a serious infection — sepsis, a bloodstream infection, or a drug-resistant organism such as CRE — after an ERCP, colonoscopy, bronchoscopy, or another procedure using a reusable scope, the proof is in records and laboratory samples that do not last forever. Culture isolates, device-tracking logs, and surveillance-culture histories are exactly the evidence that links a device to an infection, and knowing what to ask for — before it is discarded — can be the difference between a preserved case and a lost one. Our guide to the signs an infection was caused by a scope can help you understand whether your situation fits the pattern.

A short, no-obligation review can tell you whether the facts warrant pulling those records and whether a filing deadline may be approaching. We represent patients nationwide. Free case review. No Fees Unless We Recover Money for You.

Frequently Asked Questions

How do investigators prove a specific scope caused a patient’s infection?

Investigators combine three kinds of proof. First, epidemiology: they look for a cluster of patients who all underwent a procedure with the same device and then grew the same unusual organism in the same window. Second, device sampling: the CDC’s duodenoscope surveillance protocol has facilities brush the scope’s tip and flush its channel, then culture the sample to see whether the same bug is living on the device. Third, DNA fingerprinting: laboratories use pulsed-field gel electrophoresis and whole-genome sequencing to compare the patient’s organism with the one found on the scope and with other patients’ isolates. When those genetic fingerprints match, the link between the device and the infection is far stronger than timing alone.

What is whole-genome sequencing and why does it matter in a scope infection case?

Whole-genome sequencing (WGS) reads the entire DNA of a bacterium so two samples can be compared at the level of individual genetic letters. In outbreak investigations it is used alongside older methods to tell whether the organism from a patient, the organism from a scope, and the organisms from other patients are the same strain or merely the same species. Because WGS has higher resolution than the older pulsed-field gel electrophoresis method, a close genetic match between a patient’s superbug and a scope’s superbug can be powerful evidence that the device was the source rather than a coincidence.

Does a hospital keep records that could link a scope to my infection?

Often, yes. Many facilities keep device-tracking logs that record which specific scope, by serial number, was used on which patient, along with reprocessing logs and — where a surveillance program exists — culture results for individual scopes over time. The CDC has noted that a duodenoscope culture database can be used to trace an infection back to a specific device. Culture isolates from patients are also frequently retained by hospital or public health laboratories. These records are kept on routine retention schedules and can be discarded over time, so identifying and preserving them early can matter.

What if my infection was an isolated case and not part of a known outbreak?

Many scope-related infections are never publicly announced as an outbreak, and a single case can still be investigated. The same tools apply on a smaller scale: the organism cultured from the patient, the device-tracking record for the scope used, any surveillance cultures for that device, and — where isolates are preserved — DNA comparison. Whether an individual has a claim depends on the specific facts, the strength of the causation evidence, and the deadlines that apply. A lawyer’s job is to gather the records and lab evidence early and have qualified experts evaluate whether they support the connection.

Sources

• Centers for Disease Control and Prevention — “Interim Duodenoscope Surveillance Protocol” and accompanying FAQs (2015 sampling-and-culturing method: brushing the distal end and flushing the channel; note that a duodenoscope culture database can be used to trace an infection to a specific device). cdc.gov
• Epstein L, Hunter JC, Arwady MA, et al. “New Delhi metallo-β-lactamase–producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes.” JAMA, 2014;312(14):1447–1455 (molecular characterization linking a CRE outbreak to ERCP duodenoscopes). pubmed.ncbi.nlm.nih.gov
• Centers for Disease Control and Prevention — PulseNet (national molecular subtyping network; historical use of pulsed-field gel electrophoresis and transition to whole-genome sequencing for outbreak detection). cdc.gov/pulsenet
• “Use of whole genomic sequencing to detect New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli outbreak associated with endoscopic procedures.” Infection Control & Hospital Epidemiology (Cambridge University Press) (WGS used to detect and confirm an endoscopy-associated outbreak). cambridge.org
• U.S. Food & Drug Administration — “Infections Associated with Reprocessed Duodenoscopes” (recognition that reusable duodenoscopes can remain contaminated after reprocessing; post-market sampling findings). fda.gov

This article is for general informational purposes only and is not legal or medical advice. It summarizes published research, public health protocols, and regulatory communications as of the publication date; scientific methods and standards can change, and this article does not describe the outcome of any client’s case. The existence of investigative methods such as culturing and genetic typing is evidence to be evaluated on the facts, not proof of any individual’s claim. Nothing here creates an attorney-client relationship, and no result is promised or implied. Past results do not guarantee future outcomes. Deadlines and legal standards vary by state and by the facts of each case. If you believe you may have a claim, consult a licensed attorney promptly.